Also, our finding that increased RNase1 expression was accompanied by M2-like macrophage polarization through the RNase1/ALK axis suggested that treatment with an ALKi in combination with an anti-PD-1 antibody decreases immunosuppression in HCC patients with high RNase1 expression (Fig. 7e). Here, ALK is linked to hepatocellular carcinoma.